Calasia Pharmaceuticals, Inc.;Sanford-Burnham Medical Research Institute
发明人:
Prasad, Sridhar G.,Cosford, Nicholas
申请号：
AU2013263420
公开号：
AU2013263420A1
申请日:
2013.05.15
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present application describes organic compounds that inhibit the activity of cytosolic heat shock protein Hsp90. Also described are methods useful for prophylaxis, treatment, or amelioration of symptoms of diseases or conditions that are responsive to inhibition of Hsp90 activity, such as neurological diseases, proliferative disorders, and infection.
